Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EMBC is expected to report earnings to fall 18.85% to 52 cents per share on May 09
Q1'25
Est.
$0.53
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.28
Q1'24
Beat
by $0.27
The last earnings report on February 06 showed earnings per share of 64 cents, beating the estimate of 49 cents. With 639.71K shares outstanding, the current market capitalization sits at 764.07M.